...
首页> 外文期刊>Journal of Pharmacy and Pharmacology >In-vitro and in-vivo antitumour activity of physalins B and D from Physalis angulata.
【24h】

In-vitro and in-vivo antitumour activity of physalins B and D from Physalis angulata.

机译:酸浆中physalins B和D的体外和体内抗肿瘤活性。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We have evaluated the in-vitro and in-vivo antitumour activity of physalin B and physalin D isolated from the aerial parts of Physalis angulata. In-vitro, both compounds displayed considerable cytotoxicity against several cancer cell lines, showing IC50 values in the range of 0.58 to 15.18 microg mL(-1) for physalin B, and 0.28 to 2.43 microg mL(-1) for physalin D. The antitumour activity of both compounds was confirmed in-vivo using mice bearing sarcoma 180 tumour cells. The in-vivo antitumour activity was related to the inhibition of tumour proliferation, as observed by the reduction of Ki67 staining in tumours of treated animals. Histopathological examination of the kidney and liver showed that both organs were affected by physalin treatment, but in a reversible manner. These compounds were probably responsible for the previously described antitumour activity of ethanol extracts of P. angulata, and their identification and characterization presented here could explain the ethnopharmacological use ofthis species in the treatment of cancer.
机译:我们已经评估了从酸浆空地中分离出的physalin B和physalin D的体外和体内抗肿瘤活性。在体外,这两种化合物对多种癌细胞系均显示出显着的细胞毒性,对于藻红蛋白B的IC50值范围为0.58至15.18 microg mL(-1),对于藻红蛋白D的IC50值范围为0.28至2.43 microg mL(-1)。使用带有肉瘤180肿瘤细胞的小鼠体内证实了这两种化合物的抗肿瘤活性。体内抗肿瘤活性与肿瘤增殖的抑制有关,如通过在被治疗动物的肿瘤中Ki67染色的减少所观察到的。肾脏和肝脏的组织病理学检查显示,这两个器官均受到physalin治疗的影响,但以可逆的方式受到影响。这些化合物可能是先前描述的Angulata乙醇提取物的抗肿瘤活性的原因,在此给出的鉴定和表征可以解释该物种在癌症治疗中的民族药理学用途。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号